Daewoong Pharmaceutical Co., Ltd (KRX:069620)

Daewoong Pharmaceutical Revenue

Daewoong Pharmaceutical had revenue of 377.80B KRW in the quarter ending March 31, 2026, with 5.98% growth. This brings the company's revenue in the last twelve months to 1.59T, up 10.31% year-over-year. In the year 2025, Daewoong Pharmaceutical had annual revenue of 1.57T with 10.42% growth.

• Revenue (ttm): 1.59T
• Revenue Growth: +10.31%
• P/S Ratio: 0.88
• Revenue / Employee: 968.49M
• Employees: 1,644
• Market Cap: 1.39T

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.57T	148.21B	10.42%
Dec 31, 2024	1.42T	47.35B	3.44%
Dec 31, 2023	1.38T	95.24B	7.44%
Dec 31, 2022	1.28T	127.12B	11.03%
Dec 31, 2021	1.15T	97.55B	9.24%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 6, 2026

Data Sources Report a data error